The largest database of trusted experimental protocols

4 protocols using tracrrna

1

Preparation of Dual-guide RNAs for CRISPR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dual-guide RNAs were prepared as described previously (13 (link)). Briefly, DNA oligonucleotide templates for crRNA and trans-activating CRISPR RNA (tracrRNA) were purchased from Integrated DNA Technologies (IDT). The crRNA template sequences were as follows: 5′-TAATACGACTCACTATAGNNNNNNNNNNNNNNNNNNNNGTTTTAGAGCTATGCTGTTTTG-3′, where the 20 Ns represent the 20 nucleotide target regions (Table S2). The tracrRNA template sequence was as follows: 5′-TAATACGACTCACTATAGGACAGCATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTT-3′. Then, crRNA templates for every target were pooled. The tracrRNA and pooled crRNA templates were then transcribed using T7 RNA polymerase (NEB) for 2 h at 37°C. crRNAs and tracrRNAs were purified using AMPure magnetic beads and then annealed together at an equimolar ratio to form 40 μM dual-guide RNAs. These dual-guide RNAs were stored at single-use aliquots at −80°C for a year. Immediately prior to use, the dual-guide RNAs were annealed at 95°C for 30 s, then allowed to cool at room temperature.
+ Open protocol
+ Expand
2

CRISPR-Cas9 Genome Editing in C. elegans

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genome editing was performed using CRISPR/Cas9 as described (Paix et al., 2015 (link)). Briefly, purified Cas9 (NEB), tracrRNA, dpy-10 and alg-1 crRNA, and repair templates were incubated at 37°C for ten minutes for in vitro assembly, then loaded for injection. Worms were screened for rollers, bred to separate dpy-10 from alg-1 edits, and sequenced. tracrRNA was purchased from Dharmacon (Lafayette, CO). The sequences of the tracrRNA and repair template sequences are provided in the Key Resources Table.
+ Open protocol
+ Expand
3

In vitro CRISPR-Cas9 DNA Cleavage Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
174CRISPR RNA and tracrRNA (IDT cat# 1072532) were purchased from IDT and annealed to form crRNA174:tracrRNA RNA duplexes according Alt-R CRISPR-Cas9: In vitro cleavage of target DNA with ribonucleoprotein complex protocol (IDT). All RNA oligonucleotides used in this study are listed in Supplementary Data File 2.Target DNA substrates were generated by PCR of purified φNM4γ4 genomic DNA with Phusion DNA Polymerase (Thermo) using oPN144 and oPN562 and then purified by gel extraction. Cleavage assays were preformed similarly as described previously (Jinek et al., 2012 (link)). Briefly, crRNA:tracrRNA and Cas9 (NEB #MO386) were allowed form RNP complexes at room temperature for 10 minutes and then diluted to a final concentration of 6.25, 12.5, 25, 50 and 100 nM following to the addition of target DNA. All reactions were incubated at 37°C for 5 minutes before the digestion with proteinase K (NEB #P8107) to stop the reactions and liberate target DNA and then stored at −80°C until ready for further analyzed. Samples were visualized on 2% agarose gel with SYBR Gold Nucleic Acid Gel Stain (Invitrogen #S11494) and the abundance of cleavage products quantified by automated electrophoresis and imaging using a Tapestation 4200 (Agilent).
+ Open protocol
+ Expand
4

CRISPR/Cas9-mediated p2ry12 Mutagenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Somatic mosaic p2ry12 mutations were generated via a CRISPR/Cas9 approach as described before (Tsarouchas et al., 2018 (link)). The CrRNA for p2yr12 (target sequence: 5′-CCAGTTCTACTACCTGCCCACGG-3′, targeting a bsl1 restriction enzyme site), the control CrRNA (target sequence: 5′-CCTCTTACCTCAGTTACAATTTATA-3′) and the TraCrRNA were ordered from Merck KGaA (Germany, Darmstadt). The injection mix included 1 μl TraCrRNA 250 ng/μl, 1 μl CrRNA 250 ng/ul, 1 μl Cas9 protein 1 μM (NEB). To knock out p2ry12 and obtain AKT1 expression in the same larva, a Tol2-pDEST-lexOP:AKT1-lexOP:tagRFP was co-injected with the CRISPR/Cas9 injection mix of Cas9 protein, TraCrRNA, and p2ry12 CrRNA or control CrRNA. To obtain experimental controls, the Tol2-pDEST-lexOP:tagRFP-pA was co-injected. To confirm p2yr12 locus had been mutated restriction fragment length polymorphism (RFLP) analysis was performed using the bsl1 enzyme (NEB). The PCR primer pair used was: Forward primer: 5’-AGCTCAGCTTCTCCAACAGC-3’; Reverse primer: 5’GCTACATTGGCAT CGGATAA-3’. PCR products were digested with the bsl1 restriction enzyme (55°C for 1 hr).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!